And the involvement of the SPHK1 in CSC functioning has been recently investigated in several malignancies, including glioblastoma [67], melanoma [68], hepatocellular carcinoma [69], and breast adenocarcinoma [70]. This evidence concerns the gene SPHK1 and melanoma.